Stock Snapshot from
GenVec IncAdd to My Watchlist
GNVC:USNASDAQ CMIndustry: Medical-Biomedical/Gene
- 0.66Last
- 0.03 -4.36%Today's Change
- 0.69Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | -1.080 |
| EPS: Year Est. 12/13 ttm | -0.510 |
| EPS: Quarterly Actual 12/12 | -0.24 |
| EPS: Quarterly Est. 3/13 | -0.13 |
| Price/Earnings ttm | -- |
| Relative Price/Earnings | -- |
| Earnings Growth Rate | -87.93 |
Company Description
| GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. The Company specializes in the treatment of cancers, including pancreatic cancer, esophageal cancer, rectal caner, and head and neck cancer. The Company is also involved in studies involving hearing loss and balance disorders. GenVec also develops vaccines for infectious diseases. | |
| Revenue | $9 million |
| Net Income | $-14 million |
| Total Assets | $17 million |
| Employees | 75 |
| Web Site | www.genvec.com |
Latest Headlines
No news available.
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.